Loading data
AXTANYSE
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 5.12 bn USD | 5.28 bn USD | 5.18 bn USD | 4.88 bn USD | 4.42 bn USD |
| Cost of revenue | 3.36 bn USD | 3.48 bn USD | 3.57 bn USD | 3.47 bn USD | 2.99 bn USD |
| Research and development expense | 71 m USD | 74 m USD | 74 m USD | 66 m USD | 62.4 m USD |
| Selling, general and administrative expense | 805 m USD | 847 m USD | 840 m USD | 772 m USD | 738.7 m USD |
| Operating profit | 735 m USD | 706 m USD | 588 m USD | 423 m USD | 462.4 m USD |
| Interest expense | 176 m USD | 205 m USD | 213 m USD | 139.8 m USD | 134.2 m USD |
| Profit before tax | 546 m USD | 496 m USD | 355 m USD | 257 m USD | 340.5 m USD |
| Income tax expense | 167 m USD | 105 m USD | 86 m USD | 65 m USD | 76.1 m USD |
| Net income (reported basis) | 379 m USD | 391 m USD | 269 m USD | 192 m USD | 264 m USD |
| Basic earnings per share | 1.75 USD/share | 1.78 USD/share | 1.21 USD/share | 0.86 USD/share | 1.14 USD/share |
| Diluted earnings per share | 1.74 USD/share | 1.78 USD/share | 1.21 USD/share | 0.86 USD/share | 1.14 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.